Table 3 reports reduction of several RNA levels by RGZ treatment in CHF including NPR, PDE and cGK family (namely NPR1, PDEs 2 and 3 in the cortex and NPRs 1‐2, PDE3 and cGKII in the inner medulla), to levels similar to those in control rats. The gene discussed is PRKG1; the disease is congestive heart failure.